Prices delayed by at least 15 minutes | Print
Cizzle Biotechnology Holdings PLC (CIZ)
ORD 0.01PThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Company profile
Cizzle Biotechnology Holdings PLC is a cancer diagnostics company. It is engaged in development of test for the early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker.
Address
Heslington Hall
Heslington
York
GBR
YO10 5DD
Telephone
+44 207264444
Forecast key dates
| Name | Key Date |
|---|---|
| Cizzle Biotechnology Holdings PLC Second Quarter Earnings Results for 2026 | 2026-09-30T00:00:00 |
| Cizzle Biotechnology Holdings PLC Annual General Meeting for 2025 | 2026-06-30T11:00:00 |
| Cizzle Biotechnology Holdings PLC Annual Report for 2025 | 2026-04-30T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Cizzle Biotechnology Holdings PLC Second Quarter Earnings Results for 2025 | 2025-09-30T00:00:00 |
| Cizzle Biotechnology Holdings PLC Annual General Meeting for 2024 | 2025-06-30T11:00:00 |
| Cizzle Biotechnology Holdings PLC Annual Report for 2024 | 2025-04-30T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.